TEVA · earnings call history
Teva Q1 FY26 — Strong Innovative Portfolio Growth and Strategic Emalex Acquisition
Read the briefTeva Q4 FY25 — Strong Innovative Portfolio Growth and Pipeline Progress
Read the briefTeva Q3 FY25 — Strong Innovative Portfolio Drives 11th Consecutive Quarter of Growth
Read the briefBrowse all US companies on the earnings-call register.